{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:07:10Z","timestamp":1790802430573,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T00:00:00Z","timestamp":1510617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.nbd.2017.11.002","type":"journal-article","created":{"date-parts":[[2017,11,4]],"date-time":"2017-11-04T18:17:14Z","timestamp":1509819434000},"page":"218-230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Increased motor neuron resilience by small molecule compounds that regulate IGF-II expression"],"prefix":"10.1016","volume":"110","author":[{"given":"Teresia M.","family":"Osborn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Beagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Isacson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2017.11.002_bb0005","doi-asserted-by":"crossref","DOI":"10.1038\/srep25960","article-title":"Differential neuronal vulnerability identifies IGF-2 as a protective factor in ALS","volume":"6","author":"Allodi","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2017.11.002_bb0010","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/ajhp\/55.10.981a","article-title":"FDA approves oral therapy for erectile dysfunction","volume":"55","author":"Anon","year":"1998","journal-title":"Am. J. Health Syst. Pharm. AJHP Off. J Am. Soc. Health Syst. Pharm."},{"key":"10.1016\/j.nbd.2017.11.002_bb0015","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neulet.2010.10.074","article-title":"The phosphodiesterase type-5 inhibitor, tadalafil, improves depressive symptoms, ameliorates memory impairment, as well as suppresses apoptosis and enhances cell proliferation in the hippocampus of maternal-separated rat pups","volume":"488","author":"Baek","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2017.11.002_bb0020","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuron.2006.09.018","article-title":"ALS: a disease of motor neurons and their nonneuronal neighbors","volume":"52","author":"Boillee","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2017.11.002_bb0025","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1212\/WNL.51.2.583","article-title":"A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS\/IGF-I study group","volume":"51","author":"Borasio","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2017.11.002_bb0030","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00401-012-1058-5","article-title":"Unravelling the enigma of selective vulnerability in neurodegeneration: motor neurons resistant to degeneration in ALS show distinct gene expression characteristics and decreased susceptibility to excitotoxicity","volume":"125","author":"Brockington","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2017.11.002_bb0035","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nbt.1529","article-title":"Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling","volume":"27","author":"Chambers","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.nbd.2017.11.002_bb0040","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1161\/STROKEAHA.113.003606","article-title":"Sildenafil mediates blood-flow redistribution and neuroprotection after neonatal hypoxia-ischemia","volume":"45","author":"Charriaut-Marlangue","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.nbd.2017.11.002_bb0045","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nature09667","article-title":"A critical role for IGF-II in memory consolidation and enhancement","volume":"469","author":"Chen","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2017.11.002_bb0050","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.3892\/etm.2016.3210","article-title":"Proteomic analysis of cerebrospinal fluid in amyotrophic lateral sclerosis","volume":"11","author":"Chen","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.nbd.2017.11.002_bb0055","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1093\/hmg\/ddi178","article-title":"Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection","volume":"14","author":"Chung","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2017.11.002_bb0060","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/nature00819","article-title":"Placental-specific IGF-II is a major modulator of placental and fetal growth","volume":"417","author":"Constancia","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2017.11.002_bb0065","doi-asserted-by":"crossref","first-page":"141ra190","DOI":"10.1126\/scitranslmed.3003985","article-title":"Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease","volume":"4","author":"Cooper","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.nbd.2017.11.002_bb0070","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1111\/j.1476-5381.2011.01517.x","article-title":"Sildenafil restores cognitive function without affecting beta-amyloid burden in a mouse model of Alzheimer's disease","volume":"164","author":"Cuadrado-Tejedor","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2017.11.002_bb0075","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1210\/edrv-10-1-68","article-title":"Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations","volume":"10","author":"Daughaday","year":"1989","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.nbd.2017.11.002_bb0080","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/0092-8674(91)90513-X","article-title":"Parental imprinting of the mouse insulin-like growth factor II gene","volume":"64","author":"DeChiara","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2017.11.002_bb0085","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","article-title":"Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS","volume":"72","author":"DeJesus-Hernandez","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2017.11.002_bb0090","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0014-5793(97)01434-8","article-title":"Regulation of a promoter from the mouse insulin like growth factor II gene by glucocorticoids","volume":"419","author":"Dell","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.nbd.2017.11.002_bb0095","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.stem.2008.09.017","article-title":"Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation","volume":"3","author":"Di Giorgio","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.nbd.2017.11.002_bb0100","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.stem.2012.11.011","article-title":"A TALEN genome-editing system for generating human stem cell-based disease models","volume":"12","author":"Ding","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.nbd.2017.11.002_bb0105","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1172\/JCI115042","article-title":"Insulin-like growth factor II-mediated proliferation of human neuroblastoma","volume":"87","author":"El-Badry","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2017.11.002_bb0110","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0898-6568(01)00163-2","article-title":"Cyclic GMP-dependent protein kinase potentiates serotonin-induced Egr-1 binding activity in PC12 cells","volume":"13","author":"Esteve","year":"2001","journal-title":"Cell. Signal."},{"key":"10.1016\/j.nbd.2017.11.002_bb0115","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrn3209","article-title":"The many faces of insulin-like peptide signalling in the brain","volume":"13","author":"Fernandez","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2017.11.002_bb0120","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nrm1050","article-title":"Mannose 6-phosphate receptors: new twists in the tale","volume":"4","author":"Ghosh","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.nbd.2017.11.002_bb0125","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/brain\/awq167","article-title":"Global gene expression profiling of somatic motor neuron populations with different vulnerability identify molecules and pathways of degeneration and protection","volume":"133","author":"Hedlund","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2017.11.002_bb0130","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0021-9258(17)42357-X","article-title":"Inhibition of protein phosphatases activates P4 promoter of the human insulin-like growth factor II gene through the specific promoter element","volume":"269","author":"Hyun","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2017.11.002_bb0135","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1523\/JNEUROSCI.5258-07.2008","article-title":"Neuron-specific expression of mutant superoxide dismutase is sufficient to induce amyotrophic lateral sclerosis in transgenic mice","volume":"28","author":"Jaarsma","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2017.11.002_bb0140","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1126\/science.1086137","article-title":"Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model","volume":"301","author":"Kaspar","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.nbd.2017.11.002_bb0145","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.stem.2014.03.004","article-title":"Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1","volume":"14","author":"Kiskinis","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.nbd.2017.11.002_bb0150","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1212\/WNL.49.6.1621","article-title":"Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS\/IGF-I study group","volume":"49","author":"Lai","year":"1997","journal-title":"Neurology"},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2017.11.002_bb0155","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1038\/sj.ijir.3901207","article-title":"Tissue expression, distribution, and regulation of PDE5","volume":"16","author":"Lin","year":"2004","journal-title":"Int. J. Impot. Res."},{"key":"10.1016\/j.nbd.2017.11.002_bb0160","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0896-6273(00)80997-6","article-title":"Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis","volume":"20","author":"Lin","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2017.11.002_bb0165","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1212\/WNL.59.7.1077","article-title":"The overlap of amyotrophic lateral sclerosis and frontotemporal dementia","volume":"59","author":"Lomen-Hoerth","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2017.11.002_bb0170","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1474-4422(12)70043-1","article-title":"Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study","volume":"11","author":"Majounie","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2017.11.002_bb0175","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1002\/jnr.21788","article-title":"In vivo effects of phosphodiesterase inhibition on basal cyclic guanosine monophosphate levels in the prefrontal cortex, hippocampus and cerebellum of freely moving rats","volume":"86","author":"Marte","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2017.11.002_bb0180","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/01.wnl.0000191326.40772.62","article-title":"Pentoxifylline in ALS: a double-blind, randomized, multicenter, placebo-controlled trial","volume":"66","author":"Meininger","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2017.11.002_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017240","article-title":"Phosphodiesterase 7 inhibition preserves dopaminergic neurons in cellular and rodent models of Parkinson disease","volume":"6","author":"Morales-Garcia","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2017.11.002_bb0190","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nn1876","article-title":"Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons","volume":"10","author":"Nagai","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2017.11.002_bb0195","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1254\/jphs.10R01FM","article-title":"Advanced research on dopamine signaling to develop drugs for the treatment of mental disorders: biochemical and behavioral profiles of phosphodiesterase inhibition in dopaminergic neurotransmission","volume":"114","author":"Nishi","year":"2010","journal-title":"J. Pharmacol. Sci."},{"issue":"625","key":"10.1016\/j.nbd.2017.11.002_bb0200","first-page":"e611","article-title":"Sildenafil ameliorates cognitive deficits and tau pathology in a senescence-accelerated mouse model","volume":"33","author":"Orejana","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2017.11.002_bb0205","first-page":"552","article-title":"Nitric oxide and cGMP analogs activate transcription from AP-1-responsive promoters in mammalian cells","volume":"9","author":"Pilz","year":"1995","journal-title":"FASEB J. Off. Pub. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.nbd.2017.11.002_bb0210","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0306-4522(02)00199-9","article-title":"Effects of two selective phosphodiesterase type 5 inhibitors, sildenafil and vardenafil, on object recognition memory and hippocampal cyclic GMP levels in the rat","volume":"113","author":"Prickaerts","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2017.11.002_bb0215","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0014-2999(01)01614-4","article-title":"cGMP, but not cAMP, in rat hippocampus is involved in early stages of object memory consolidation","volume":"436","author":"Prickaerts","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2017.11.002_bb0220","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1471-4159.2008.05825.x","article-title":"Phosphodiesterase 5 inhibitors prevent 3,4-methylenedioxymethamphetamine-induced 5-HT deficits in the rat","volume":"108","author":"Puerta","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2017.11.002_bb0225","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.nbd.2010.01.013","article-title":"Sildenafil protects against 3-nitropropionic acid neurotoxicity through the modulation of calpain, CREB, and BDNF","volume":"38","author":"Puerta","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2017.11.002_bb0230","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2147\/NDT.S2447","article-title":"Role of phosphodiesterase 5 in synaptic plasticity and memory","volume":"4","author":"Puzzo","year":"2008","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.nbd.2017.11.002_bb0235","doi-asserted-by":"crossref","first-page":"8075","DOI":"10.1523\/JNEUROSCI.0864-09.2009","article-title":"Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-beta load in an Alzheimer's disease mouse model","volume":"29","author":"Puzzo","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2017.11.002_bb0240","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.nlm.2012.02.008","article-title":"Phosphodiesterase type 5 (PDE5) inhibition improves object recognition memory: indications for central and peripheral mechanisms","volume":"97","author":"Reneerkens","year":"2012","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.nbd.2017.11.002_bb0245","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","article-title":"A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD","volume":"72","author":"Renton","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2017.11.002_bb0250","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nn.3584","article-title":"State of play in amyotrophic lateral sclerosis genetics","volume":"17","author":"Renton","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2017.11.002_bb0255","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1212\/01.wnl.0000172911.39167.b6","article-title":"Prevalence and patterns of cognitive impairment in sporadic ALS","volume":"65","author":"Ringholz","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2017.11.002_bb0260","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0896-6273(00)80086-0","article-title":"Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate","volume":"16","author":"Rothstein","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2017.11.002_bb0265","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1089\/dna.1990.9.725","article-title":"Evolution of insulin-like growth factor II: characterization of the mouse IGF-II gene and identification of two pseudo-exons","volume":"9","author":"Rotwein","year":"1990","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.nbd.2017.11.002_bb0270","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1038\/npp.2009.24","article-title":"Phosphodiesterase inhibitors enhance object memory independent of cerebral blood flow and glucose utilization in rats","volume":"34","author":"Rutten","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"Suppl. 4","key":"10.1016\/j.nbd.2017.11.002_bb0275","article-title":"Comparative selectivity profiles of tadalafil, sildenafil, and vardenafil using an in vitro phosphodiesterase activity assay","volume":"14","author":"S\u00e1enz de Tejada","year":"2002","journal-title":"Int. J. Impot. Res."},{"key":"10.1016\/j.nbd.2017.11.002_bb0280","doi-asserted-by":"crossref","first-page":"5688","DOI":"10.1523\/JNEUROSCI.0111-12.2012","article-title":"IkappaB kinase\/nuclear factor kappaB-dependent insulin-like growth factor 2 (Igf2) expression regulates synapse formation and spine maturation via Igf2 receptor signaling","volume":"32","author":"Schmeisser","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2017.11.002_bb0285","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/17482960701856300","article-title":"Design, power, and interpretation of studies in the standard murine model of ALS","volume":"9","author":"Scott","year":"2008","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.nbd.2017.11.002_bb0290","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1212\/01.wnl.0000335970.78664.36","article-title":"Subcutaneous IGF-1 is not beneficial in 2-year ALS trial","volume":"71","author":"Sorenson","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2017.11.002_bb0295","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/978-1-4615-2988-0_7","article-title":"Transcriptional and post-transcriptional regulation of the human IGF-II gene expression","volume":"343","author":"Sussenbach","year":"1993","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.nbd.2017.11.002_bb0300","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00001756-199701200-00003","article-title":"Immediate early gene induction by natriuretic peptides in PC12 phaeochromocytoma and C6 glioma cells","volume":"8","author":"Thiriet","year":"1997","journal-title":"Neuroreport"},{"key":"10.1016\/j.nbd.2017.11.002_bb0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.celrep.2014.03.019","article-title":"Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons","volume":"7","author":"Wainger","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2017.11.002_bb0310","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1067\/mcp.2002.123554","article-title":"Sildenafil for primary and secondary pulmonary hypertension","volume":"71","author":"Watanabe","year":"2002","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.nbd.2017.11.002_bb0315","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/bies.201500198","article-title":"The evolving landscape of imprinted genes in humans and mice: conflict among alleles, genes, tissues, and kin","volume":"38","author":"Wilkins","year":"2016","journal-title":"BioEssays News Rev. Mol. Cell. Dev. Biol."},{"key":"10.1016\/j.nbd.2017.11.002_bb0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141078","article-title":"Insulin like growth factor 2 expression in the rat brain both in basal condition and following learning predominantly derives from the maternal allele","volume":"10","author":"Ye","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2017.11.002_bb0325","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0006-8993(98)00157-7","article-title":"Biallelic expression of all four IGF-II promoters and its association with increased methylation of H19 gene in human brain","volume":"792","author":"Zhan","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2017.11.002_bb0330","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1161\/01.STR.0000034399.95249.59","article-title":"Sildenafil (Viagra) induces neurogenesis and promotes functional recovery after stroke in rats","volume":"33","author":"Zhang","year":"2002","journal-title":"Stroke"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996117302449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996117302449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T21:04:15Z","timestamp":1771967055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996117302449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":66,"alternative-id":["S0969996117302449"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2017.11.002","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased motor neuron resilience by small molecule compounds that regulate IGF-II expression","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2017.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}